Prognostic significance of osteopontin expression in human prostate cancer

被引:85
作者
Forootan, SS
Foster, CS
Aachi, VR
Adamson, J
Smith, PH
Lin, K
Ke, YQ
机构
[1] Univ Liverpool, Mol Pathol Lab, Sch Clin Lab Sci, Fac Med, Liverpool L69 3GA, Merseyside, England
[2] Univ Liverpool, Div Haematol, Sch Clin Lab Sci, Fac Med, Liverpool L69 3GA, Merseyside, England
基金
英国医学研究理事会;
关键词
prostate carcinoma; osteopontin; benign prostate hyperplasia (BPH); Gleason scores; patient survival;
D O I
10.1002/ijc.21619
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To test the hypothesis that expression of osteopontin (OPN), an integrin-binding glycoprotein, can independently predict the potential aggressiveness of prostate cancer, the status of OPN expression in benign and malignant prostate cancer cell lines and tissues was analysed by Western blot and immunohistochemistry. Amongst the four prostate cell lines analysed, the level of OPN expressed in the benign PNT-2 cells was set at 1, the relative level of OPN expressed in the weakly malignant cell line LNCaP was increased to 1.5. In the highly malignant cell lines Du-145 and PC-3, the level of OPN expression was further increased to 2.9 and 4.4, respectively. An increased expression of OPN was also observed in the prostate tissue samples. When the level of OPN in normal tissue was set at 1, its level in benign prostate hyperplasia (BPH) was similar at 0.99 +/- 0.2, whereas the OPN level in the highly malignant carcinoma tissue was greatly increased by nearly 6-fold to 5.9 +/- 0.3. Amongst the 116 cases examined immunocytochemically, of the 10 normal cases, 3 (30%) were unstained and 7 (70%) stained weakly positive (+). Amongst the 36 BPH samples, 32 (89%) stained weakly positive (+) and 4 (11%) were unstained (-). For the 70 carcinomas analysed, 31 (44%) stained strongly positive (+++), 20 (29%) stained moderately positive (++) and 19 (27%j stained weakly positive (+). These results showed that the level of OPN expressed between the normal and the BPH samples was not significantly different (Fisher's exact test, p = 0.16). However, in comparison to that in the BPH samples, the expression of OPN in the carcinoma tissues was significantly increased (Chi-square test, p < 0.0001). Kaplan-Meier survival analysis showed that the increased level of OPN expression was significantly (n = 70, p = 0.03) associated with reduced survival time of the patients. The OPN expression was increased with the increasing Gleason scores of the carcinomas (Chi-square test, p < 0.001). The results in our study support our hypothesis and suggest that the increased OPN level may be involved in the malignant transformation of prostate epithelial cells and OPN expression level is an important determinant for patient survival. (c) 2005 Wiley-Liss, Inc.
引用
收藏
页码:2255 / 2261
页数:7
相关论文
共 34 条
[1]   High-level expression of cutaneous fatty acid-binding protein in prostatic carcinomas and its effect on tumorigenicity [J].
Adamson, J ;
Morgan, EA ;
Beesley, C ;
Meil, YQ ;
Foster, CS ;
Fujii, H ;
Rudland, PS ;
Smith, PH ;
Ke, YQ .
ONCOGENE, 2003, 22 (18) :2739-2749
[2]   Osteopontin enhances the cell proliferation induced by the epidermal growth factor in human prostate cancer cells [J].
Angelucci, A ;
Festuccia, C ;
Gravina, GL ;
Muzi, P ;
Bonghi, L ;
Vicentini, C ;
Bologna, M .
PROSTATE, 2004, 59 (02) :157-166
[3]   Thymosin beta 15: A novel regulator of tumor cell motility upregulated in metastatic prostate cancer [J].
Bao, LR ;
Loda, M ;
Janmey, PA ;
Stewart, R ;
AnandApte, B ;
Zetter, BR .
NATURE MEDICINE, 1996, 2 (12) :1322-1328
[4]  
BERTHON P, 1995, INT J ONCOL, V6, P333
[5]   IMMORTALIZATION OF HUMAN ADULT NORMAL PROSTATIC EPITHELIAL-CELLS BY LIPOSOMES CONTAINING LARGE T-SV40 GENE [J].
CUSSENOT, O ;
BERTHON, P ;
BERGER, R ;
MOWSZOWICZ, I ;
FAILLE, A ;
HOJMAN, F ;
TEILLAC, P ;
LEDUC, A ;
CALVO, F .
JOURNAL OF UROLOGY, 1991, 146 (03) :881-886
[6]   Osteopontin stimulates cell motility and nuclear factor κB-mediated secretion of urokinase type plasminogen activator through phosphatidylinositol 3-kinase/Akt signaling pathways in breast cancer cells [J].
Das, R ;
Mahabeleshwar, GH ;
Kundu, GC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (31) :28593-28606
[7]   Differential expression of acidic and basic fibroblast growth factors in benign prostatic hyperplasia identified by immunohistochemistry [J].
Deshmukh, N ;
Scotson, J ;
Dodson, AR ;
Smith, PH ;
Ke, Y ;
Foster, CS .
BRITISH JOURNAL OF UROLOGY, 1997, 80 (06) :869-874
[8]  
Fedarko NS, 2001, CLIN CANCER RES, V7, P4060
[9]  
Foster CS, 1999, BJU INT, V83, P171
[10]   PREDICTION OF PROGNOSIS FOR PROSTATIC ADENOCARCINOMA BY COMBINED HISTOLOGICAL GRADING AND CLINICAL STAGING [J].
GLEASON, DF ;
MELLINGE.GT .
JOURNAL OF UROLOGY, 1974, 111 (01) :58-64